Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 25 | 24 | −1 |
| Shares | 320.2K | 276.4K | −43.8K (−13.7%) |
| Value | $166.5K | $254.1K | +$87.7K (+52.7%) |
New holders (3)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Inc | 320 | $285 | 0.00% |
| Jones Financial Companies LLLP | 60 | $55 | 0.00% |
| MAI Capital Management | 2 | $2 | 0.00% |
Sold out (4)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 25,610 | $13.3K |
| Two Sigma Securities, LLC | 20,974 | $10.9K |
| JPMorgan Chase & Co | 904 | $470 |
| GWM Advisors LLC | 1 | $1 |